Company
Pharming Group
Nasdaq: PHAR
Leiden, Netherlands biotech founded in 1988. Develops and markets protein replacement and immunology therapies for rare disease.
1 story
Regulatory News has published 1 story about Pharming Group on 17 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 17 September 2026.
This page is generated from Regulatory News’ editorial coverage of Pharming Group. It is not an advertisement.
On the record
- Company
- Pharming Group N.V. (Nasdaq: PHAR)
- Headquarters
- Leiden, Netherlands
- Founded
- 1988, Leiden
- Regulator
- U.S. Food and Drug Administration (CDER)
- Latest milestone
- FDA approval, pediatric Joenja (leniolisib) for APDS
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
